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Abstract
Aims/hypothesis We determined the genetic contribution of
18 anthropometric and metabolic risk factors of type 2
diabetes using a young healthy twin population.
Methods Traits were measured in 240 monozygotic (MZ)
and 138 dizygotic (DZ) twin pairs aged 18 to 34 years.
Twins were recruited from the Belgian population-based
East Flanders Prospective Twin Survey, which is charac-
terised by its accurate zygosity determination and extensive
collection of perinatal and placental data, including infor-
mation on chorionicity. Heritability was estimated using
structural equation modelling implemented in the Mx
software package.
Results Intra-pair correlations of the anthropometric and
metabolic characteristics did not differ between MZ mono-
chorionic and MZ dichorionic pairs; consequently heri-
tabilities were estimated using the classical twin approach.
For body mass, BMI and fat mass, quantitative sex
differences were observed; genetic variance explained 84,
85 and 81% of the total variation in men and 74, 75 and
70% in women, respectively. Heritability estimates of the
waist-to-hip ratio, sum of four skinfold thicknesses and lean
body mass were 70, 74 and 81%, respectively. The
heritability estimates of fasting glucose, fasting insulin,
homeostasis model assessment of insulin resistance and
beta cell function, as well as insulin-like growth factor
binding protein-1 levels were 67, 49, 48, 62 and 47%, in
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e-mail: aimee.paulussen@gen.unimaas.nlthat order. Finally, for total cholesterol, LDL-cholesterol,
HDL-cholesterol, total cholesterol:HDL-cholesterol ratio,
triacylglycerol, NEFA and leptin levels, genetic factors
explained 75, 78, 76, 79, 58, 37 and 53% of the total
variation, respectively.
Conclusions/interpretation Genetic factors explain the
greater part of the variation in traits related to obesity,
glucose intolerance/insulin resistance and dyslipidaemia.
Keywords Anthropometry.Carbohydratemetabolism.
Chorionicity.EastFlandersProspectiveTwinSurvey.
Heritability.Lipidmetabolism.Metabolicriskfactors.
Structuralequationmodelling.Twinstudy.Type2diabetes
Abbreviations
A additive genetic effects
C common environmental effects
D non-additive genetic effects
DC dichorionic
DZ dizygotic
DZF dizygotic women
DZM dizygotic men
DZOS dizygotic opposite sex
E unique environmental effects
EFPTS East Flanders Prospective Twin Survey
IGFBP-1 insulin-like growth factor binding protein-1
MC monochorionic
MZ monozygotic
MZF monozygotic women
MZM monozygotic men
S4SF sum of four skinfold thicknesses
Introduction
Type 2 diabetes is a heterogeneous disease that involves
both genetic and environmental factors. Its incidence is
rising rapidly worldwide and consequently much research
is focused on the genetic components of the disorder, in
order to get a better understanding of the pathogenesis and
eventually to achieve better, more personalised diagnostics,
treatment and prevention [1].
The starting point in the search for genes is to estimate
the degree of heritability of intermediate traits leading to the
disease in the studied population. Heritability is the
proportion of phenotypic variation of a trait that can be
attributed to genetic variation [2]. The degree of heritability
is an important determinant of the power to detect and
localise disease-related genes [3]. Although heritabilities
can in principle be estimated from all kinds of related
individuals, twin studies allow the variation to be split up
into genetic, shared environmental and unique environmen-
tal components, thus offering one of the most valid
estimations [2].
A variety of studies estimating heritabilities of risk factors
of type 2 diabetes in adult twins have been carried out. A
summary of the larger studies (>200 twin pairs) on the risk
factors obesity, glucose intolerance/insulin resistance and
dyslipidaemia is provided in Electronic Supplementary
Material (ESM) Table 1. The heritability of BMI, the most
frequently used measure of obesity, has been estimated
extensively and ranges between 40 and 90% [4–21]. For all
the other traits, fewer studies have been performed; the total
variation of fasting glucose and fasting insulin is explained
by genetic factors for 12 to 50% [22, 23] and 14 to 54% [7,
18, 22–24], respectively; for total cholesterol, LDL-choles-
terol, HDL-cholesterol and triacylglycerol heritability esti-
mates range between 0 and 98% [7, 10, 13, 17, 21, 25–34].
In addition to sample numbers and statistical methodologies
used, the large variation in heritability estimates may also be
caused by the genetic background of the studied populations
and the environmental exposures experienced (see ESM
Table 1). For the majority of intermediate traits related to
type 2 diabetes, the number of larger studies performed is
quite small and studies in which heritabilities of several risk
factors of type 2 diabetes were estimated in the same
population are even scarcer (ESM Table 1).
To determine the genetic contribution to type 2 diabetes,
we used variance components modelling to estimate the
heritabilities of 18 anthropometric and metabolic risk
factors of the disease, including parameters quantifying
obesity, glucose intolerance/insulin resistance and dys-
lipidaemia. In addition, we also determined the heritabilities
of the hormones insulin-like growth factor binding protein-
1 (IGFBP-1), which has been shown to be related to several
cardiovascular risk factors, and leptin, which plays a role as
satiety signal regulating body composition and energy
expenditure [35]. The characteristics were measured in
756 healthy twins, divided into 240 monozygotic (MZ) and
138 dizygotic (DZ) twin pairs in the age range of 18 to
34 years, recruited from the East Flanders Prospective Twin
Survey (EFPTS).
Methods
Participants The EFPTS is a population-based twin register
that started in 1964 and has recorded all multiple births in
the Belgian Province of East Flanders until the present day.
A detailed description of the EFPTS has been published
[36]. Zygosity was determined using sequential analysis
based on sex, fetal membranes, umbilical cord blood
groups, placental alkaline phosphatase and DNA marker
analysis. Between July 1964 and May 1982, the Twin
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Health Organization criteria for live born infants (birth-
weight ≥500 g or gestational age ≥22 weeks if birthweight
unknown). Pairs of whom one or both members were
stillborn, died in neonatal or later life or suffered from
major congenital malformations were excluded. We ran-
domly contacted 803 pairs using an envelope system. To
assure equally distributed groups, we stratified for birth
year and zygosity. Since the twin survey was originally set
up to determine chorionicity, the number of MZ twin pairs
was over sampled. Eventually, 424 twin pairs (52.7%)
volunteered to participate in the study. Sex, gestational age
and birthweight did not differ between participants and
non-participants (i.e. those who where eligible, but refused
to participate or had not been contacted) (p>0.05), although
participants were slightly older than the non-participants
and the proportion of monochorionic (MC) twins was
higher in the group of participants (p<0.05). A detailed
description of the methods used to measure the anthropo-
metric and metabolic characteristics of the twins is provided
in the Electronic Supplementary Material. For the present
analysis participants suffering from type 1 diabetes were
excluded and only twin pairs of whom both members
participated were incorporated. Consequently, phenotypic
data were available for 378 complete pairs, consisting of
113 monozygotic men (MZM), 127 monozygotic women
(MZF), 46 DZ men (DZM), 49 DZ women (DZF) and
43 DZ opposite sex (DZOS) pairs. Additionally, for the
analysis of lipid and carbohydrate parameters, participants
taking drugs with potential effects on lipid or carbohydrate
metabolism were excluded (n=11). Twins were randomly
assigned to be the first or the second member of a pair. The
Ethics Committee of the Faculty of Medicine of the
Katholieke Universiteit Leuven approved the project and
all participants gave informed consent.
Descriptive statistical analysis Anthropometric and meta-
bolic characteristics are expressed as mean±SD according
to chorion type, for men and women separately. BMI, sum
of four skinfold thicknesses (S4SF), fat mass, IGFBP-1,
fasting insulin, insulin resistance, beta cell function, leptin,
total cholesterol:HDL-cholesterol ratio and triacylglycerol
values had a skewed distribution. After transforming these
data into natural logarithms a normal distribution was
obtained and the transformed data were used when
performing statistical tests. Differences in means between
MZ MC, MZ dichorionic (DC) and DZ twins were
calculated using the PROC MIXED method implemented
in SAS version 9.1 (SAS Institute, Cary, NC, USA). A
random intercept model was used, where the intercept of
each twin pair was modelled as a function of the population
intercept plus a unique contribution of the twin pair. In
addition, we allowed the variance–covariance structure of
the random intercept to differ between MZ MC, MZ DC
and DZ pairs. Differences in means were considered
significant if the 2 df F test indicated p<0.05.
For all traits, effects of potential covariates were also
checked using the random intercept model of PROC
MIXED, where the variance–covariance structure of the
random intercept was allowed to differ between MZ and
DZ pairs. The variables BMI, WHR and S4SF were
checked for the effect of potential confounding by sex
and age; body mass, fat mass and lean body mass were
checked for the effect of sex, age and height; the blood
parameters were checked for the effect of sex, age and fat
(BMI, WHR or S4SF). Covariates were considered signif-
icant if p<0.05. Intra-pair correlation coefficients were
calculated for MZ MC and MZ DC twin pairs and for each
of the five sex by zygosity groups (MZM, MZF, DZM,
DZF and DZOS) before and after adjustment for significant
covariates using the Mx software package [37]. In addition,
we used a linear regression analysis to test whether twin
correlations differed between MZ MC and MZ DC twin
pairs before and after adjusting for covariates.
Twin model fitting Twin methodology makes use of the fact
that MZ twins are genetically identical, whereas DZ twins
share 50% of their segregating genes. Assuming that MZ
and DZ twins share their common environment to the same
extent, a higher concordance rate in MZ twins than in DZ
twins reflects genetic influences. To estimate the genetic
and environmental components of variance of the traits,
twin model fitting of raw data was implemented using the
statistical package Mx [37]. Scripts were downloaded from
the GenomEUtwin Mx-script library (http://www.psy.vu.nl/
mxbib/). Univariate twin analyses were performed, where
the phenotypic variance can be decomposed into additive
genetic (A, additive effects of genes on multiple loci), non-
additive genetic (D, interactions between alleles at the same
locus [dominance] or on different loci [epistasis]), common
environmental (C, environmental effects shared by twins
reared in the same family) and unique environmental effects
(E, environmental effects unique to the individual). MZ
twins are assumed to share the same A and D genetic
variance; DZ pairs are assumed to share one-half of the A
variance and one-quarter of the D variance. The C variance
is assumed to be the same for both MZ and DZ twin pairs.
The broad sense heritability (H
2), which estimates the
extent to which variation of a trait in a population can be
explained by genetic variation, is defined as the proportion
of genetic variance to total phenotypic variance. As non-
additive genetic (D) and shared environmental effects (C)
cannot be identified simultaneously in data from twins
reared together, ACE and ADE models were fitted
separately. The significance of variance components A, C
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and comparing the fit of the models [5].
To test whether genetic and environmental factors
influence a trait to the same degree in men and women,
we compared a quantitative heterogeneity model (variance
components free to differ across sexes) with a homogeneity
model (variance components equal for both sexes). In
addition, we verified whether the distribution of a trait
differed among men and women by testing a scalar model,
which assumes that the female variance components are
common multiples of the male variance components. In this
model the variance components were constrained to be
equal for both sexes, but total variances were allowed to
differ between men and women (Fig. 1)[ 5].
If for a certain trait the correlation of the opposite-sex
pairs is smaller than the correlations for the like-sexed DZ
pairs, it is suggested that the correlation between additive
genetic factors in opposite-sex pairs is smaller than 0.5.
This indicates that different genetic factors influence this
trait in men and women. To test this, a full heterogeneity
model (variance components free to differ across sexes,
plus the correlation between the additive genetic factors in
opposite-sex pairs free to be estimated between 0 and 0.5)
was compared with a quantitative heterogeneity model.
All variance components were estimated both unadjusted
and adjusted for the covariates. In the models, phenotypic
means were adjusted for significant covariates by modelling
them as definition variables in the means model. The
difference in fit between the nested models was evaluated
with the likelihood ratio χ
2 test, which uses the difference
between the −2log likelihood of the full and the restricted
model. This difference is distributed as χ
2. The df of the
test were calculated as the difference in df between the
models. When the χ
2 was not statistically significant (p<
0.05), the most parsimonious model was selected, i.e. the
model with the best fit given the number of df. When
comparing the fit of non-nested models (e.g. ACE with
ADE), the model with the lowest Akaike’s information
criterion was preferred.
Results
Descriptive statistical analysis The mean values of the
anthropometric and metabolic characteristics of the twins
are presented in Table 1 according to chorion type for men
and women separately. In men, fasting glucose levels were
lower in DZ twins than in MZ MC and MZ DC twins. In
women, MZ DC twins were younger and had lower total
cholesterol and LDL-cholesterol levels than MZ MC and
DZ twins (Table 1).
The covariates adjusted for, the intra-pair correlations of
MZ MC and MZ DC pairs, and the intra-pair correlations of
each sex by zygosity group before and after adjustment are
summarised in Table 2. Intra-pair correlations of the
anthropometric and metabolic characteristics did not differ
between MZ MC and MZ DC pairs (p>0.05). Adjusting for
covariates strongly reduced the correlations of the leptin
concentrations. The correlations of the other traits were
only minimally affected by adjustment. Twin correlations
for total cholesterol and LDL-cholesterol were high in both
Fig. 1 Path diagram for a univariate quantitative heterogeneity (a),
scalar (b) and homogeneity (c) model only presenting opposite sex
pairs. Observed phenotypes (PM and PW) for the male and female
twins are shown in rectangles, while latent factors (A, C and E) and
latent phenotypes (LPM and LPW)a r es h o w ni nc i r c l e s .P a t h
coefficients of observed variables on the different latent factors are
shown in lower case: a, additive genetic effect; c, common
environmental effect; e, unique environmental effect; k, scalar factor.
The genetic correlation is represented by rg (1 for MZ and 0.5 for DZ
twins) and the common environmental correlation is represented by rc
(1 for MZ and DZ twins)
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effect. The DZ correlations of IGFBP-1, fasting insulin and
insulin resistance were less then one-half of the MZ
correlations, suggesting that non-additive genetic effects
might be important. Correlations of the other traits were in
agreement with a model containing additive genetic and
unique environmental influences (Table 2).
Twin model fitting The variance components and 95% CIs
of the best fitting models before and after adjustment for
covariates are presented in Table 3. The best fitting model
for lean body mass and the obesity parameters body mass,
BMI, WHR, S4SF and fat mass was an AE model
containing a major genetic component. For total cholesterol
and LDL-cholesterol, the ACE model was the best fitting
model. However, after adjusting for covariates, the AE
model became the best fitting model. For IGFBP-1, fasting
insulin and insulin resistance, a DE model containing a
non-additive genetic and unique environmental component
had the best fit. The variation of the remaining blood
parameters, including fasting glucose, beta cell function,
leptin, HDL-cholesterol, total cholesterol:HDL-cholesterol
ratio, triacylglycerol and NEFA levels were best explained
by an AE model (Table 3).
Quantitative sex differences were present in body mass,
BMI, WHR, S4SF, fat mass, lean body mass, leptin and
total cholesterol:HDL-cholesterol ratio, because variance
components estimates were significantly different between
men and women (Table 3). The influences of additive
genetic factors were larger in men than in women. For some
traits, scalar sex differences were observed, implying that
although variance components are equal across sexes, the
total variances differ. As a result, total variance of IGFBP-
1, HDL-cholesterol and NEFA levels in women was larger
than in men, but smaller for fasting glucose and HDL-
cholesterol levels (Table 3).
After adjusting for covariates, quantitative sex differences
remained significant only for body mass, BMI and fat mass
(Table 3). In addition, scalar sex differences were signifi-
cant for WHR, S4SF, lean body mass, IGFBP-1, fasting
glucose, leptin, HDL-cholesterol, total cholesterol:HDL-
cholesterol ratio and NEFA levels. Total variance of
IGFBP-1, HDL-cholesterol and NEFA levels was larger in
Table 1 Anthropometric and metabolic characteristics of the twin population according to chorion type for men and women separately in the
EFPTS
Characteristic Men Women
MZ MC MZ DC DZ p value MZ MC MZ DC DZ p value
n 134 92 135 142 112 141
Age (years)
a 25.3±4.5 25.0±4.9 25.7±4.7 0.33 25.9±4.4 24.0±4.8 25.7±4.6 0.02
Body height (cm) 178.0±5.7 178.3±7.2 178.4±6.5 0.92 165.0±6.3 165.6±6.1 166.2±6.4 0.59
Body mass (kg) 70.7±10.5 69.6±8.4 70.9±10.2 0.67 60.5±9.7 60.5±10.6 60.8±10.2 0.98
BMI (kg/m
2) 22.1±1.1 21.8±1.1 22.1±1.2 0.73 22.0±1.2 21.8±1.2 21.8±1.2 0.86
WHR (%) 83.4±5.4 83.4±5.8 82.8±5.5 0.84 73.4±4.5 73.3±4.6 72.5±4.3 0.30
S4SF (mm)
b 35.9±1.5 34.6±1.5 34.8±1.5 0.89 57.1±1.4 55.6±1.5 53.6±1.4 0.50
Fat mass (kg)
b 11.9±1.6 11.2±1.5 12.2±1.5 0.33 16.9±1.3 16.7±1.4 16.8±1.3 0.95
Lean body mass (kg) 57.7±6.9 57.6±6.0 57.7±6.6 0.99 42.9±5.1 43.1±5.6 43.4±6.0 0.89
IGFBP-1 (ng/ml)
b 11.0±1.9 10.3±1.8 11.5±1.9 0.46 16.8±2.0 16.6±2.2 18.4±2.3 0.58
Fasting insulin (pmol/l)
b 33.5±1.5 32.7±1.6 32.7±1.6 0.94 38.6±1.5 35.8±1.6 40.1±1.5 0.24
Insulin resistance (HOMA)
b 1.2±1.6 1.2±1.6 1.2±1.6 0.69 1.3±1.5 1.2±1.7 1.4±1.5 0.26
Fasting glucose (mmol/l) 5.0±0.5 4.9±0.4 4.8±0.4 0.01 4.5±0.3 4.6±0.4 4.6±0.4 0.23
Beta cell function (HOMA)
b 77.2±1.5 78.2±1.6 86.5±1.7 0.10 135.2±1.7 115.7±1.6 126.7±1.6 0.17
Leptin (ng/ml)
b 1.7±3.0 1.4±2.9 1.7±3.0 0.42 11.5±2.1 11.2±2.2 11.5±1.9 0.92
Total cholesterol (mmol/l) 4.8±0.9 4.7±1.0 4.9±1.1 0.31 5.3±0.9 4.9±0.8 5.3±1.0 0.006
LDL-cholesterol (mmol/l) 3.0±0.9 2.9±0.9 3.1±1.0 0.35 3.1±0.8 2.7±0.8 2.9±0.8 0.012
HDL-cholesterol (mmol/l) 1.3±0.3 1.3±0.3 1.4±0.4 0.94 1.8±0.4 1.8±0.4 1.9±0.4 0.39
Total cholesterol:HDL-cholesterol ratio
b 3.6±1.4 3.5±1.3 3.7±1.4 0.67 3.0±1.3 2.8±1.3 2.9±1.3 0.34
Triacylglycerol (mmol/l)
b 0.9±1.6 0.9±1.5 0.9±1.5 0.78 0.9±1.5 0.9±1.5 0.9±1.5 0.83
NEFA (mmol/l) 0.5±0.2 0.5±0.2 0.5±0.2 0.05 0.7±0.2 0.7±0.3 0.7±0.2 0.81
Data are expressed as mean±SD
HOMA, homeostasis model assessment
ap value calculated using standard linear regression, because convergence criteria could not be met using a random intercept model
bGeometric mean±SD
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mass, fasting glucose, leptin and total cholesterol:HDL-
cholesterol ratio (Table 3).
The adjusted correlations of WHR, fasting insulin and
triacylglycerol levels for opposite-sex pairs were smaller
than the correlations for like-sexed DZ pairs, suggesting
that different genetic factors influence this trait in men and
women (Table 2). However, the correlations between the
additive genetic factors in opposite-sex pairs were not
significantly smaller than 0.5 (p>0.05).
Broad-sense heritability estimates (encompassing both
additive and non-additive genetic effects) were slightly
lower after adjusting for covariates, with the exception of
total cholesterol and LDL-cholesterol, which had a higher
heritability after adjustment (Table 3).
In summary, heritability estimates of body mass, BMI and
fat mass were 84, 85 and 81% for men and 74, 75 and 70%
for women, respectively. WHR, S4SF and lean body mass
had heritability estimates of 70, 74 and 81%, correspond-
ingly. For fasting glucose, fasting insulin, insulin resistance,
beta cell function and IGFBP-1 levels, genetic factors
explained 67, 49, 48, 62 and 47% of the total variation,
respectively. Finally, heritability estimates of total cholester-
ol, triacylglycerol, HDL-cholesterol, LDL-cholesterol, total
cholesterol:HDL-cholesterol ratio, NEFA and leptin levels
were 75, 58, 76, 78, 79, 37 and 53%, respectively (Table 3).
Discussion
To determine the genetic contribution to type 2 diabetes, we
estimated the heritabilities of 18 anthropometric and
metabolic characteristics related to this disease, including
parameters quantifying obesity, glucose intolerance/insulin
resistance and dyslipidaemia. The traits were measured in
138 DZ and 240 MZ young healthy twin pairs recruited
from the population-based EFPTS [36].
Obesity, defined as excess accumulation of adipose
tissue, is a complicated trait to measure and numerous
methods exist for its determination [38]. In the present
study several parameters defining obesity, including body
mass, BMI, S4SF, WHR and fat mass were used and
heritability estimates ranged from 70 to 85%. According to
ESM Table 1, the heritabilities identified by us for BMI and
body mass are in agreement with those reported in other twin
studies, but the heritability identified by us for WHR is
somewhat higher [7, 15, 18, 39]. Heritability estimates for
S4SF and fat mass are not often reported and therefore we
were not able to make a valid comparison. Despite the
variety of measurements used to quantify obesity, the
heritabilities of the different measurements were consis-
tently in a high range, indicating that the contribution of
genetic factors to total phenotypic variation in obesity is of
great importance in the studied twin sample.
Table 2 Intra-pair correlations of MZ MC and MZ DC pairs, and of each sex by zygosity group before and after adjusting for covariates in the
EFPTS
Characteristic Monozygotic Monozygotic Dizygotic Covariates
MC DC Men Women Men Women OS
n (of pairs) 138 102 113 127 46 49 43
Body mass 0.85/0.79 0.84/0.76 0.86/0.82 0.76/0.73 0.38/0.28 0.58/0.57 0.26/0.35 Sex, age, height
BMI 0.80/0.78 0.81/0.77 0.86/0.83 0.77/0.74 0.46/0.31 0.53/0.56 0.47/0.46 Age
WHR 0.87/0.69 0.88/0.71 0.79/0.74 0.70/0.66 0.39/0.28 0.44/0.48 0.31/0.15 Sex, age
S4SF 0.82/0.73 0.84/0.75 0.81/0.79 0.72/0.68 0.46/0.37 0.64/0.63 0.36/0.31 Sex, age
Fat mass 0.85/0.78 0.85/0.75 0.85/0.82 0.73/0.69 0.46/0.36 0.43/0.46 0.42/0.35 Sex, age
Lean body mass 0.93/0.81 0.93/0.79 0.86/0.82 0.79/0.78 0.43/0.39 0.65/0.58 0.25/0.39 Sex, age, height
IGFBP-1 0.49/0.39 0.60/0.53 0.55/0.51 0.45/0.43 0.31/0.21 0.08/0.06 0.12/−0.05 Sex, age, BMI
Fasting insulin 0.57/0.48 0.52/0.50 0.49/0.45 0.58/0.52 0.07/0.13 0.18/0.19 0.07/−0.01 Age, S4SF
Insulin resistance 0.54/0.47 0.53/0.50 0.49/0.46 0.57/0.51 0.03/0.08 0.14/0.17 0.04/−0.05 Sex, age, S4SF
Fasting glucose 0.74/0.66 0.73/0.67 0.65/0.65 0.70/0.69 0.28/0.24 0.57/0.60 0.31/0.32 Sex, BMI
Beta cell function 0.71/0.58 0.66/0.60 0.52/0.50 0.68/0.66 0.32/0.40 0.47/0.46 0.37/0.33 Sex, age, S4SF
Leptin 0.85/0.53 0.85/0.57 0.70/0.58 0.64/0.52 0.35/0.02 0.66/0.31 0.38/0.37 Sex, age, S4SF
Total cholesterol 0.76/0.74 0.77/0.72 0.78/0.74 0.73/0.73 0.52/0.51 0.51/0.44 0.63/0.51 Age, S4SF
LDL-cholesterol 0.78/0.79 0.81/0.74 0.81/0.79 0.77/0.75 0.52/0.51 0.59/0.52 0.68/0.58 Sex, age, S4SF
HDL-cholesterol 0.78/0.71 0.84/0.77 0.75/0.76 0.74/0.74 0.31/0.30 0.44/0.44 0.52/0.52 Sex, S4SF
Total cholesterol:HDL-cholesterol ratio 0.81/0.78 0.86/0.81 0.84/0.82 0.78/0.76 0.50/0.41 0.50/0.49 0.65/0.54 Age, WHR
Triacylglycerol 0.58/0.56 0.67/0.60 0.59/0.54 0.63/0.60 0.29/0.41 0.34/0.34 0.16/0.17 Sex, S4SF
NEFA 0.49/0.35 0.43/0.39 0.39/0.38 0.34/0.37 0.10/0.14 0.20/0.18 0.25/0.26 Sex, S4SF
Values are unadjusted intra-pair correlation/adjusted intra-pair correlation.
OS, opposite sex
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mass, BMI and fat mass, with heritability estimates of 84, 85
and 81% in men and 74, 75 and 70% in women, respectively.
Our results confirm those from other twin studies reporting
quantitative sex differences in the heritability of body mass
and BMI [4–6, 9, 20, 40]. However, in other twin studies
the highest heritability estimates were not always observed
in men (ESM Table 1), indicating that the influence of
environmental factors in the total variation of these traits
according to sex may vary in different populations.
In the present study, 49% of the total variation of fasting
insulin was explained by genetic factors, which is in
agreement with other twin studies (ESM Table 1)[ 41,
42]. The heritability of fasting glucose (H
2=67%) was
higher than those observed in other twin studies, where it
ranged between 12 and 58% (ESM Table 1)[ 42, 43]. The
heritabilities of beta cell function (H
2=62%) and insulin
resistance (H
2=48%) was not higher than those of fasting
glucose (H
2=67%) and fasting insulin levels (H
2=49%).
This indicates that no additional power was obtained by
calculating these alternative phenotypic markers with the
homeostasis model assessment.
The variation of total cholesterol, triacylglycerol, HDL-
cholesterol, LDL-cholesterol and total cholesterol:HDL-
cholesterol ratio was primarily explained by additive
genetic factors, accounting for 75, 58, 76, 78 and 79% of
the total variance, respectively. No evidence was observed
for quantitative sex differences in heritability estimates for
these traits. The percentages are slightly higher than the
heritability estimates reported in the literature, but are in the
same high range (ESM Table 1). To the best of our
knowledge, ours is the first large twin study reporting the
heritability of NEFA levels, which was 37%. This is
somewhat surprising, since excessive circulating fatty acids
represent a major contributor to the development of insulin
resistance [44]. The heritability determined for NEFA levels
in the current study was low compared with those reported
for the other blood lipid parameters, indicating that
environmental factors, e.g. nutrition, may be more impor-
tant in determining the variation of NEFA levels than
genetic factors.
Additive genetic variance explained 53% of the variation
of total leptin concentration. In other western adult twin
studies, heritabilities of total leptin concentrations ranged
from 34 to 55% [45, 46], which is in agreement with our
findings. Compared with other traits, the correlations and
heritability estimates of leptin were strongly reduced after
adjusting for covariates, which is probably caused by the
adjustment for fat (using S4SF). This is not very surprising,
since leptin is synthesised in and secreted from adipose
tissue and plasma leptin levels are increased in obese
humans in direct proportion to body fat mass [35]. The
heritability of IGFBP-1 (H
2=47%) levels determined in our
study was also relatively high, since the heritability in two
other twin studies ranged from 0 to 36% [41, 47].
Interestingly, the heritabilities of IGFBP-1 levels in the
latter studies were determined in older twins (mean age
63 years). This might suggest that the heritability of
IGFBP-1 decreases with advancing age. Longitudinal twin
studies need to be carried out to verify this observation.
We are the first to report that a model containing non-
additive instead of additive genetic factors is the best-fitting
model for insulin resistance, fasting insulin and IGFBP-1
levels [7, 18, 22, 24, 41–43]. In addition to the twin model
fitting procedure, twin correlations can also give an
impression of whether non-additive genetic effects might
be involved, i.e. a DZ correlation of less than one-half of
the MZ correlation suggests a contribution of non-additive
genetic effects [18, 41–43]. The smaller sample size of
some studies could be responsible for their not observing a
DE model. Furthermore, the presence of non-additive
genetic effects has not always been tested. However, if
non-additive genetic effects are observed, this implies that a
part of the variance is explained by interactions between
alleles at the same locus or on different loci. Although this
observation is likely to be the result of lack of power, we
cannot exclude real non-additive genetic effects in the
absence of additive genetic effects, as these three traits are
closely related to or are a direct gene product.
MZ MC twins have a more adverse intra-uterine
environment than MZ DC and DZ twins, resulting in a
significantly lower weight at birth and higher perinatal
mortality and morbidity [36]. Hence, it has been hypoth-
esised that for disorders like type 2 diabetes, in the
development of which prenatal environment plays a role,
the classical twin study might be an unreliable method of
estimating heritabilities [48, 49]. In the current twin sample,
intra-pair correlations did not differ between MZ MC and
MZ DC twins, suggesting that the chorion type of MZ twins
did not bias the heritability estimates of the studied traits.
With the exception of NEFA levels, the genetic
contribution to the traits studied in our twin sample was
high. When comparing the heritability values found by us
with those reported in other twin studies (Electronic
Supplementary Material Table 1), our heritability estimates
are in a slightly higher range. An important aspect affecting
heritability estimates is the accuracy of the zygosity
determination used in the present study via sequential
analysis based on sex, fetal membranes, umbilical cord
blood groups, placental alkaline phosphatase and DNA
marker analysis. In other twin studies, zygosity was often
determined using questionnaires [4], which sometimes
leads to misclassification and consequently to underestima-
tion of heritability [50]. Our high heritability estimates
might also be a consequence of the homogeneous compo-
sition of the studied sample. All twins included were born
2114 Diabetologia (2007) 50:2107–2116in the Belgian province of East Flanders, which is a
relatively small but rather densely populated area [36].
Another factor possibly contributing to the high heritability
estimates is age, as shown by the fact that several large twin
studies have reported a decrease in the heritability of
obesity (BMI) in adults with increasing age [5, 12, 16]. Our
twin sample is young (mean=25 years) and the age range is
small (18–34 years). As the power to detect quantitative trait
loci is positively correlated with the size of the genetic effect
[3], our study suggests that the search for candidate genes
might be more efficient in a young homogeneous population.
In conclusion, this study is the first large study to give a
comprehensive overview of the heritabilities of multiple
risk factors related to type 2 diabetes within the same twin
sample. The variation of traits related to obesity, glucose
intolerance/insulin resistance and dyslipidaemia in this
Belgian twin sample is in general highly explained by
genetic factors. These high heritabilities are very promising
for follow-up to this research, in which, in order to explain
some of the genetic variance observed, sib-pair linkage
analyses will be performed using microsatellite markers
located in the close vicinity of selected candidate genes.
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